Analysis of DNA data reveals important information in largest diabetes genetic study to date….
Read More »Role of the Kidneys, Part 2
With the recent report in The Lancet that the number of overweight and obese people on the planet has topped 2.1 billion, this week’s Homerun Slides will give you a closer look at the issue in some specific countries as well as the importance of taking action sooner rather than …
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #49: Pharmacotherapy of Type 2 Diabetes, Part 8
Richard S. Beaser, MD This week’s excerpt covers the following topics: Drug interactions with potential for clinical significance for metformin Contraindications and precautions for metformin Class contraindications and precautions for TZD’s Which TZD interactions are serious and how it is metabolized
Read More »HealthSpot Stations
HealthSpot Stations Cleveland Clinic and HealthSpot are forming a joint venture that will offer patients convenient, alternative options to access health care through HealthSpot’s virtual walk-in kiosks. HealthSpot stations — private, 8-by-5-foot enclosures outfitted with touch screens, integrated medical devices and videoconferencing capabilities — will enable Cleveland Clinic medical providers …
Read More »Heart Risk and Death between 40% and 50% Greater for Women with Diabetes
Women with diabetes were at 40% to 50% greater risk for developing and dying from coronary heart disease than diabetic men, and sex disparities in pharmacotherapy didn’t appear to explain the excess risk….
Read More »Losing Weight at Any Age Can Improve Cardiovascular Health
Weight loss at any age in adulthood is worthwhile because it could yield long-term heart and vascular benefits….
Read More »How to Establish Glucose Targets to Achieve A1c Goals
The ADAG study was able to determine the average blood glucose for premeal, postmeal and bedtime readings to achieve a variety of A1c targets….
Read More »AACE: Dulaglutide Predicts HBA1c with Fasting Blood Glucose at 2 Weeks
A study conducted in patients with type 2 diabetes receiving dulaglutide has shown that fasting blood glucose levels 2 weeks after beginning treatment are predictive of long-term glucose control as measured by HbA1c 6 months later….
Read More »AACE: Dapagliflozin Reduces Postprandial Glucose in Type 2 Diabetes
Dapagliflozin as an add-on therapy to glimepiride, pioglitazone, or sitagliptin significantly reduces postprandial plasma glucose in type 2 diabetes patients….
Read More »Reduced Systolic Blood Pressure Observed with Liraglutide
The reduced SBP was also weakly correlated with weight loss….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.